In this podcast, Vincent Lo Re, MD, MSCE, talks about the barriers to hepatitis C virus direct-acting antiviral therapy and how they can be overcome, as well as the research question he hopes to answer by the end of his carer. Read the transcript here.
Additional Resources:
- Jatt LP, Gandhi MM, Guo R, et al. Barriers to hepatitis C direct‐acting antiviral therapy among HIV/hepatitis C virus‐coinfected persons. Hepatology. Published online August 25, 2020. https://doi.org/10.1111/jgh.15228
- Center for Clinical Epidemiology and Biostatistics. Perelman School of Medicine, University of Pennsylvania. Accessed November 6, 2020. https://www.cceb.med.upenn.edu
- Penn Center for AIDS Research. Perelman School of Medicine, University of Pennsylvania. Accessed November 6, 2020. https://www.med.upenn.edu/cfar
Vincent Lo Re, MD, MSCE, is an associate professor of medicine (Infectious Diseases) and Epidemiology at the University of Pennsylvania, senior scholar in the Penn Center for Clinical Epidemiology and Biostatistics, and codirector of the Penn Center for AIDS Research Clinical Core.
